Olivier Mirguet

ORCID: 0000-0002-5486-0386
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Protein Degradation and Inhibitors
  • Asymmetric Synthesis and Catalysis
  • Multiple Myeloma Research and Treatments
  • Chemical synthesis and alkaloids
  • Synthetic Organic Chemistry Methods
  • Cancer Treatment and Pharmacology
  • Computational Drug Discovery Methods
  • Histone Deacetylase Inhibitors Research
  • Machine Learning in Materials Science
  • Tryptophan and brain disorders
  • Chemical Synthesis and Analysis
  • Catalytic Alkyne Reactions
  • Bipolar Disorder and Treatment
  • Stress Responses and Cortisol
  • RNA Interference and Gene Delivery
  • Quinazolinone synthesis and applications
  • Acute Myeloid Leukemia Research
  • Peptidase Inhibition and Analysis
  • Metabolism, Diabetes, and Cancer
  • X-ray Diffraction in Crystallography
  • Alkaloids: synthesis and pharmacology
  • Crystallization and Solubility Studies
  • Crystallography and molecular interactions
  • Cyclopropane Reaction Mechanisms
  • Oxidative Organic Chemistry Reactions

Eurofins (France)
2024

Servier (France)
2013-2022

Institut des Hautes Études Scientifiques
2018-2022

GlaxoSmithKline (France)
2009-2017

Institut de Recherche de Chimie Paris
2016

Centre National de la Recherche Scientifique
2001-2016

Chimie ParisTech
2016

Université Paris Sciences et Lettres
2016

Molecular Discovery (United Kingdom)
2014

GlaxoSmithKline (United Kingdom)
2011-2014

Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes. An integral part this mechanism occurs through lysine acetylation histone tails which are recognized by bromodomains. While the biological structural characterization many bromodomain containing proteins has advanced considerably, therapeutic tractability protein family is only now becoming understood. This paper describes discovery molecular potent (nM) small molecule inhibitors that...

10.1021/jm200108t article EN Journal of Medicinal Chemistry 2011-05-13

The bromo and extra C-terminal domain (BET) family of bromodomains are involved in binding epigenetic marks on histone proteins, more specifically acetylated lysine residues. This paper describes the discovery structure-activity relationships (SAR) potent benzodiazepine inhibitors that disrupt function BET (BRD2, BRD3, BRD4). work has yielded a potent, selective compound I-BET762 is now under evaluation phase I/II clinical trial for nuclear protein testis (NUT) midline carcinoma other cancers.

10.1021/jm401088k article EN Journal of Medicinal Chemistry 2013-09-09

Through their function as epigenetic readers of the histone code, BET family bromodomain-containing proteins regulate expression multiple genes therapeutic relevance, including those involved in tumor cell growth and inflammation. bromodomain inhibitors have profound antiproliferative anti-inflammatory effects which translate into efficacy oncology inflammation models, first compounds now progressed clinical trials. The exciting biology BETs has led to great interest discovery novel...

10.1021/jm5010539 article EN Journal of Medicinal Chemistry 2014-09-24

Multi-parameter optimization (MPO) is a major challenge in new chemical entity (NCE) drug discovery. Recently, promising results were reported for deep learning generative models applied to de novo molecular design, but, our knowledge, until now no report was made of the value this technology addressing MPO an actual discovery project. In study, we demonstrate benefit applying AI real We evaluate potential ligand-based design using accelerate obtention lead compounds meeting 11 different...

10.1002/jcc.26826 article EN cc-by-nc-nd Journal of Computational Chemistry 2022-02-26

Abstract Mycolactones are complex macrolides responsible for a severe necrotizing skin disease called Buruli ulcer. Deciphering their functional interactions is of fundamental importance the understanding, and ultimately, control this devastating mycobacterial infection. We report herein diverted total synthesis approach mycolactones analogues provide first insights into structure–activity relationship based on cytopathic assays L929 fibroblasts. The lowest concentration inducing effect was...

10.1002/chem.201102542 article EN Chemistry - A European Journal 2011-11-30

Soluble guanylate cyclase (sGC), the primary mediator of nitric oxide (NO) bioactivity, exists as reduced (NO-sensitive) and oxidized (NO-insensitive) forms. We tested hypothesis that cardiovascular protective effects NO-insensitive sGC activation would be potentiated under conditions oxidative stress compared to those NO-sensitive stimulation. The activator GSK2181236A [a low, non-depressor dose, a high dose which lowered mean arterial pressure (MAP) by 5-10 mmHg] equi-efficacious doses...

10.3389/fphar.2012.00128 article EN cc-by Frontiers in Pharmacology 2012-01-01

Abstract β‐Amino alcohols derived from natural amino acids have been used extensively as a powerful source of chirality. Transformation the hydroxy group these β‐amino into good leaving group, by using trifluoroacetic anhydride, led to rearranged in yields and with high enantiomeric excesses. This rearrangement has allowed transformation substituted prolinols 3‐hydroxypiperidines linear alcohols, issued acids, alcohols. Chirality, 2009. © 2009 Wiley‐Liss, Inc.

10.1002/chir.20716 article EN Chirality 2009-04-30

Bromodomains (BRDs) are small protein domains found in a variety of proteins that recognize and bind to acetylated histone tails. This binding affects chromatin structure facilitates the localisation transcriptional complexes specific genes, thereby regulating epigenetically controlled processes including gene transcription mRNA elongation. Inhibitors bromodomain extra-terminal (BET) BRD2-4 T, which prevent acetyl-modified tails, have shown therapeutic promise several diseases. We report...

10.1002/cmdc.201300259 article EN ChemMedChem 2013-09-02

Recently, we reported a novel role for KMO in the pathogenesis of acute pancreatitis (AP). A number inhibitors kynurenine 3-monooxygenase (KMO) have previously been described as potential treatments neurodegenerative conditions and particularly Huntington's disease. However, to date insufficient aqueous solubility relative their cellular potency be compatible with intravenous (iv) dosing route required AP. We identified optimized series high affinity favorable physicochemical properties. The...

10.1021/acs.jmedchem.7b00055 article EN Journal of Medicinal Chemistry 2017-03-28

Abstract The efficient gold‐catalyzed cyclization reactions of alkynyl silyl enol ethers were successfully applied to the preparation bicyclo[3.2.1]octanone derivatives. Accordingly, after optimization gold catalytic system, several bicyclic α,β‐unsaturated keto adducts synthesized in good excellent yields. process followed a major 5‐ exo via an anti addition ether π‐activated intermediate, which was demonstrated by deuterium incorporation experiment. A 6‐ endo observed for bearing...

10.1002/adsc.201501135 article EN Advanced Synthesis & Catalysis 2016-04-24

A ring expansion and a radical dehalogenation have been used as the key steps in formal total synthesis of (−)-paroxetine. The substituted piperidine precursor (−)-paroxetine was generated by means stereoselective prolinol. (© Wiley-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002)

10.1002/1099-0690(200211)2002:21<3543::aid-ejoc3543>3.0.co;2-0 article EN European Journal of Organic Chemistry 2002-10-18

A ring expansion reaction applied to a substituted prolinol has been used in order obtain the piperidine core of (-)-velbanamine, an alkaloid extracted from Tabernaemontana eglandulosa.

10.1055/s-2001-17454 article EN Synlett 2001-01-01

AMP-activated protein kinase (AMPK) is an evolutionarily conserved fuel-sensing enzyme that activated in shortage of energy and suppressed its surfeit. AMPK activation stimulates fatty acid oxidation, enhances insulin sensitivity, alleviates hyperglycemia hyperlipidemia, inhibits proinflammatory changes. Thus, a well-received therapeutic target for type 2 diabetes other metabolic disorders. Here, we will report the discovery pyrrolopyridone derivatives as direct activators. We illustrate...

10.1021/ml400157g article EN ACS Medicinal Chemistry Letters 2013-05-17

Multi-Parameter Optimization (MPO) is a major challenge in New Chemical Entity (NCE) drug discovery projects, and the inability to identify molecules meeting all criteria of lead optimization (LO) an important cause NCE project failure. Several ligand- structure-based de novo design methods have been published over past decades, some which proved useful multiobjective optimization. However, there still need for improvement better address chemical feasibility generated compounds as well...

10.26434/chemrxiv.13622417.v2 preprint EN cc-by-nc-nd 2021-01-25

Carnitine palmitoyl transferase 2 (CPT2) deficiency is one of the most common inherited fatty acid oxidation (FAO) defects and represents a prototypical mitochondrial metabolic myopathy. Recent studies have suggested pivotal role adenosine monophosphate-activated protein kinase (AMPK) in skeletal muscle plasticity homeostasis. Thus, we tested potential GSK773, novel direct AMPK activator, to improve or correct FAO capacities cells from patients harboring various mutations. We used controls'...

10.1093/hmg/ddy254 article EN Human Molecular Genetics 2018-07-07

Hydrazinocyclohexadienes, easily prepared by an ene-reaction between commercially available azodicarboxylate reagents and cyclohexadiene, are interesting substrates for desymmetrization reactions. Under Sharpless asymmetric dihydroxylation conditions, they can lead efficiently to several chiral building blocks as well advanced precursors of biologically active compounds.

10.1021/ol900779v article EN Organic Letters 2009-05-26

Multi-Parameter Optimization (MPO) is a major challenge in New Chemical Entity (NCE) drug discovery projects, and the inability to identify molecules meeting all criteria of lead optimization (LO) an important cause NCE project failure. Several ligand- structure-based de novo design methods have been published over past decades, some which proved useful multiobjective optimization. However, there still need for improvement better address chemical feasibility generated compounds as well...

10.26434/chemrxiv.13622417.v1 preprint EN cc-by-nc-nd 2021-01-22
Coming Soon ...